• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

探索在勃起功能障碍修复治疗临床试验中代表性不足的少数族裔男性的代表性:解决障碍,促进包容。

Exploring representation of underrepresented minority men in a restorative therapy clinical trial for erectile dysfunction: addressing barriers and promoting inclusion.

机构信息

Desai Sethi Urology Institute, University of Miami Miller School of Medicine, Miami, FL, USA.

Herbert Wertheim College of Medicine, Florida International University, Miami, FL, USA.

出版信息

Int J Impot Res. 2024 Aug;36(5):458-462. doi: 10.1038/s41443-023-00747-9. Epub 2023 Jul 29.

DOI:10.1038/s41443-023-00747-9
PMID:37516799
Abstract

This retrospective descriptive analysis explores underrepresented minority men in our clinical trial for restorative therapy for erectile dysfunction and to identify strategies to promote diversity and inclusion in the study population. Demographic data were collected from all participants and the prevalence in our population was compared to the source population. The proportion of individuals taking part in our clinical trial was compared to the overall disease population using the participation to prevalence ratio. Among the 61 participants enrolled in the Platelet-Rich Plasma for Erectile Dysfunction trial, 72.1% were Hispanic compared to 39.9% in the national source population. There were 27.9% non-Hispanic participants, and 41.2% non-Hispanic men in the local South Florida population. The racial composition of our study shows 80.3% of PRP participants identify as White, 16.4% as Black, and 3.4% as Asian. In the national source population, 61.8% of patients were White, 27.5% are black, and 1.5% are Asian. Through the implementation of strategies such as having Hispanic team members on the clinical trial staff and providing education and outreach materials both in Spanish and English, we were able to overcome barriers to participation in Hispanic men and potentially improve health outcomes for underrepresented minority men with erectile dysfunction.

摘要

本回顾性描述性分析探讨了我们在勃起功能障碍修复治疗临床试验中代表性不足的少数族裔男性,并确定了在研究人群中促进多样性和包容性的策略。从所有参与者中收集人口统计学数据,并将我们人群中的患病率与源人群进行比较。使用参与与患病率比比较参与我们临床试验的个体比例与总体疾病人群。在参加富血小板血浆治疗勃起功能障碍试验的 61 名参与者中,72.1%是西班牙裔,而全国源人群中这一比例为 39.9%。有 27.9%的非西班牙裔参与者,而当地南佛罗里达州的非西班牙裔男性占 41.2%。我们研究的种族构成显示,80.3%的 PRP 参与者认为自己是白人,16.4%是黑人,3.4%是亚洲人。在全国源人群中,61.8%的患者是白人,27.5%是黑人,1.5%是亚洲人。通过实施在临床试验工作人员中配备西班牙裔团队成员以及提供西班牙语和英语的教育和外展材料等策略,我们能够克服西班牙裔男性参与的障碍,并有可能改善勃起功能障碍代表性不足的少数族裔男性的健康结果。

相似文献

1
Exploring representation of underrepresented minority men in a restorative therapy clinical trial for erectile dysfunction: addressing barriers and promoting inclusion.探索在勃起功能障碍修复治疗临床试验中代表性不足的少数族裔男性的代表性:解决障碍,促进包容。
Int J Impot Res. 2024 Aug;36(5):458-462. doi: 10.1038/s41443-023-00747-9. Epub 2023 Jul 29.
2
An evaluation of race-based representation among men participating in clinical trials for prostate cancer and erectile dysfunction.对参与前列腺癌和勃起功能障碍临床试验的男性中基于种族的代表性的评估。
Contemp Clin Trials Commun. 2022 Aug 28;29:100986. doi: 10.1016/j.conctc.2022.100986. eCollection 2022 Oct.
3
Prevalence and correlates of erectile dysfunction by race and ethnicity among men aged 40 or older in the United States: from the male attitudes regarding sexual health survey.美国40岁及以上男性中按种族和族裔划分的勃起功能障碍患病率及其相关因素:来自男性性健康态度调查
J Sex Med. 2007 Jan;4(1):57-65. doi: 10.1111/j.1743-6109.2006.00340.x. Epub 2006 Nov 1.
4
Graduation and Academic Placement of Underrepresented Racial/Ethnic Minority Doctoral Recipients in Public Health Disciplines, United States, 2003-2015.代表性不足的少数族裔博士研究生在美国公共卫生学科的毕业和学术安置情况,2003-2015 年。
Public Health Rep. 2019 Jan/Feb;134(1):63-71. doi: 10.1177/0033354918814259. Epub 2018 Nov 30.
5
Assessment of the Inclusion of Racial/Ethnic Minority, Female, and Older Individuals in Vaccine Clinical Trials.评估种族/少数民族、女性和老年人在疫苗临床试验中的纳入情况。
JAMA Netw Open. 2021 Feb 1;4(2):e2037640. doi: 10.1001/jamanetworkopen.2020.37640.
6
Willingness to Participate in Health Research Among Community-Dwelling Middle-Aged and Older Adults: Does Race/Ethnicity Matter?社区中老年居民参与健康研究的意愿:种族/民族重要吗?
J Racial Ethn Health Disparities. 2021 Jun;8(3):773-782. doi: 10.1007/s40615-020-00839-y. Epub 2020 Aug 17.
7
Racial/Ethnic and Gender Disparities Over the Last Decade Within Microsurgery and Craniofacial Fellowship Training.过去十年间,在显微外科学和颅面外科学专科培训中存在种族/民族和性别差异。
Ann Plast Surg. 2023 May 1;90(5S Suppl 3):S281-S286. doi: 10.1097/SAP.0000000000003403. Epub 2023 Jan 31.
8
The role of race and ethnicity in the State Children's Health Insurance Program (SCHIP) in four states: are there baseline disparities, and what do they mean for SCHIP?种族和族裔在四个州的儿童健康保险计划(SCHIP)中的作用:是否存在基线差异,以及这些差异对儿童健康保险计划意味着什么?
Pediatrics. 2003 Dec;112(6 Pt 2):e521.
9
Disparities in the Inclusion of Racial and Ethnic Minority Groups and Older Adults in Prostate Cancer Clinical Trials: A Meta-analysis.种族和少数民族以及老年人群体在前列腺癌临床试验中纳入情况的差异:一项荟萃分析。
JAMA Oncol. 2023 Feb 1;9(2):180-187. doi: 10.1001/jamaoncol.2022.5511.
10
Underrepresented minorities in academic medicine: is Florida better off?学术医学领域中代表性不足的少数族裔:佛罗里达州的情况更好吗?
South Med J. 2014 Mar;107(3):173-6. doi: 10.1097/SMJ.0000000000000073.

本文引用的文献

1
Associations between Race and Erectile Dysfunction Treatment Patterns.种族与勃起功能障碍治疗模式之间的关联。
Urol Pract. 2022 Sep;9(5):423-430. doi: 10.1097/UPJ.0000000000000329. Epub 2022 Jul 5.
2
An evaluation of race-based representation among men participating in clinical trials for prostate cancer and erectile dysfunction.对参与前列腺癌和勃起功能障碍临床试验的男性中基于种族的代表性的评估。
Contemp Clin Trials Commun. 2022 Aug 28;29:100986. doi: 10.1016/j.conctc.2022.100986. eCollection 2022 Oct.
3
Minority Enrollment in Phase II and III Clinical Trials in Urologic Oncology.
泌尿外科肿瘤学中 II 期和 III 期临床试验的少数族裔入组情况。
J Clin Oncol. 2022 May 10;40(14):1583-1589. doi: 10.1200/JCO.21.01885. Epub 2022 Feb 23.
4
Racial Differences in Urinary Incontinence Prevalence, Overactive Bladder and Associated Bother among Men: The Multi-Ethnic Study of Atherosclerosis.种族差异与男性下尿路症状患病率、膀胱过度活动症及相关困扰:动脉粥样硬化多种族研究。
J Urol. 2021 Feb;205(2):524-531. doi: 10.1097/JU.0000000000001353. Epub 2020 Sep 10.
5
The global prevalence of erectile dysfunction: a review.勃起功能障碍的全球患病率:一项综述。
BJU Int. 2019 Oct;124(4):587-599. doi: 10.1111/bju.14813. Epub 2019 Jul 2.
6
Strategies for overcoming language barriers in research.克服研究中语言障碍的策略。
J Adv Nurs. 2020 Feb;76(2):706-714. doi: 10.1111/jan.14007. Epub 2019 Jun 17.
7
Minority Recruitment Trends in Phase III Prostate Cancer Clinical Trials (2003 to 2014): Progress and Critical Areas for Improvement.三期前列腺癌临床试验中的少数民族招募趋势(2003 年至 2014 年):进展和需要改进的关键领域。
J Urol. 2019 Feb;201(2):259-267. doi: 10.1016/j.juro.2018.09.029.
8
Global Trends and Prostate Cancer: A Review of Incidence, Detection, and Mortality as Influenced by Race, Ethnicity, and Geographic Location.全球趋势与前列腺癌:种族、族裔和地理位置对发病率、检测及死亡率影响的综述
Am J Mens Health. 2018 Nov;12(6):1807-1823. doi: 10.1177/1557988318798279. Epub 2018 Sep 11.
9
Representation of Minorities and Women in Oncology Clinical Trials: Review of the Past 14 Years.肿瘤学临床试验中少数群体和女性的代表性:对过去 14 年的回顾。
J Oncol Pract. 2018 Jan;14(1):e1-e10. doi: 10.1200/JOP.2017.025288. Epub 2017 Nov 3.
10
Underrepresentation of Hispanics and Other Minorities in Clinical Trials: Recruiters' Perspectives.临床试验中西班牙裔和其他少数族裔代表性不足:招募者的观点。
J Racial Ethn Health Disparities. 2018 Apr;5(2):322-332. doi: 10.1007/s40615-017-0373-x. Epub 2017 Apr 27.